Product NDC: | 0004-0357 |
Proprietary Name: | Pegasys |
Non Proprietary Name: | peginterferon alfa-2a |
Active Ingredient(s): | 180 ug/.5mL & nbsp; peginterferon alfa-2a |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0004-0357 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103964 |
Marketing Category: | BLA |
Start Marketing Date: | 20110329 |
Package NDC: | 0004-0357-30 |
Package Description: | 1 PACKET in 1 BOX (0004-0357-30) > 4 SYRINGE, GLASS in 1 PACKET > .5 mL in 1 SYRINGE, GLASS |
NDC Code | 0004-0357-30 |
Proprietary Name | Pegasys |
Package Description | 1 PACKET in 1 BOX (0004-0357-30) > 4 SYRINGE, GLASS in 1 PACKET > .5 mL in 1 SYRINGE, GLASS |
Product NDC | 0004-0357 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | peginterferon alfa-2a |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20110329 |
Marketing Category Name | BLA |
Labeler Name | Genentech, Inc. |
Substance Name | PEGINTERFERON ALFA-2A |
Strength Number | 180 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes | Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient] |